Sphincter Preservation for Distal Rectal Cancer: Paradise Lost? Nicholas J. PetrelliThomas K. Weber Editorial Pages: 413 - 415
Sentinel Lymphadenectomy for Melanoma—Is It a Substitute for Elective Lymphadenectomy? Charles M. BalchMerrick I. Ross Editorial Pages: 416 - 417
Refining the Optimal Technical Approach for Sentinel Node Localization in Breast Cancer Patients Kirby I. Bland Editorial Pages: 418 - 419
The Impact of Local Regional Therapy on Breast Cancer Survival David W. Kinne Editorial Pages: 420 - 421
An Expanded Diagnostic Role for Core Biopsy: Assessment of the Proportion of the Duct Carcinoma In Situ Component in Invasive Carcinomas Michael D. Lagios Editorial Pages: 422 - 423
Presidential Address Surgical Oncology: A Specialty in Evolution Edward M. Copeland III Editorial Pages: 000 - 000
Sphincter-Sparing Treatment for Distal Rectal Adenocarcinoma Glenn D. Steele Jr.James E. HerndonRobert J. Mayer Editorial Pages: 433 - 441
Efficacy of Lymphatic Mapping, Sentinel Lymphadenectomy, and Selective Complete Lymph Node Dissection as a Therapeutic Procedure for Early-Stage Melanoma Richard EssnerArnold ConfortiDonald L. Morton Editorial Pages: 442 - 449
Intradermal Radiocolloid and Intraparenchymal Blue Dye Injection Optimize Sentinel Node Identification in Breast Cancer Patients David C. LinehanArnold D. K. HillHiram S. Cody III Original Article Pages: 450 - 454
Does Local Therapy Affect Survival Rates in Breast Cancer? H. S. ShuklaJ. MelhuishL. E. Hughes Editorial Pages: 455 - 460
Accurate Prediction of the Amount of In Situ Tumor in Palpable Breast Cancers by Core Needle Biopsy: Implications for Neoadjuvant Therapy Mahmoud El-TamerConstantine AxiotisAlbert Braverman Editorial Pages: 461 - 466
Recent Advances in Melanoma Staging and Therapy Kelly M. McMastersVernon K. SondakMerrick I. Ross Editorial Pages: 467 - 475
Thrombocytopenia After Isolated Limb or Hepatic Perfusions with Melphalan: The Risk of Heparin-Induced Thrombocytopenia Iris P. MasucciKarim A. CalisMcDonald K. Horne III Editorial Pages: 476 - 480
p21Waf1/Cip1 Expression Is a Prognostic Marker in Curatively Resected Esophageal Squamous Cell Carcinoma, but Not p27Kip1, p53, or Rb Marcelo E. NitaHirokazu NagawaTetsuichiro Muto Editorial Pages: 481 - 488
Expression of p53 and RB Proteins in Squamous Cell Carcinoma of the Esophagus: Their Relationship With Clinicopathologic Characteristics Naoki HashimotoMitsuo TachibanaNaofumi Nagasue Editorial Pages: 489 - 494
Dual Roles of Peptic Ulcer in the Carcinogenesis or Extension of Early Gastric Cancer Shouji ShimoyamaYoshiaki JoujimaMichio Kaminishi Editorial Pages: 495 - 499
Functional Down-Regulation of β1 and β2 Integrins on Lamina Propria Lymphocytes (LPL) and Tumor-Infiltrating Lymphocytes (TIL) in Colorectal Cancer Patients Joji KitayamaNelson TunoHirokazu Nagawa Editorial Pages: 500 - 506
Society of Surgical Oncology: Statement on Genetic Testing for Cancer Susceptibility V. S. KlimbergS. GalandiukM. J. Edwards Editorial Pages: 507 - 509
